Clinical Trials Logo

Clinical Trial Summary

To investigate the long-term safety and maintenance of efficacy of ATX-101 in reduction of submental fat


Clinical Trial Description

In the study, patients who completed the randomized, double-blind, placebo-controlled phase 3 studies ATX-101-10-16 and ATX-101-10-17 and where recruited at German study sites are followed-up for up to 2 years. No study medication is administered in this study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02052622
Study type Interventional
Source Kythera Biopharmaceuticals
Contact
Status Completed
Phase Phase 3
Start date February 2012
Completion date December 2013

See also
  Status Clinical Trial Phase
Completed NCT04699669 - A Phase 1 Study to Evaluate the Safety and Tolerability of CBL-514 Injection on Convexity or Fullness of Abdominal Subcutaneous Fat in Healthy Volunteers Phase 1
Completed NCT02512822 - Usefulness of Non-invasive Radiofrequency Therapy for Facial Contouring N/A
Recruiting NCT06005441 - A Phase 2b Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat. Phase 2
Active, not recruiting NCT05736107 - A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat Phase 2
Not yet recruiting NCT03160976 - Cryolipolysis on Localized Adiposity N/A
Completed NCT03871556 - Diagnostic Ultrasound for Measuring Fat of the Body N/A
Completed NCT02098811 - Evaluation of the Safety and Precursors of Efficacy N/A
Active, not recruiting NCT04553627 - Feasibility of Producing the Appearance of a Gluteal Lift Post Cryolipolysis N/A
Completed NCT02539043 - Effects of Ultrasound Cavitation Focused on Located Adiposity N/A
Completed NCT01842802 - Clinical Investigation of Non Invasive Fat Reduction N/A
Completed NCT04698642 - A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of CBL-514 Injection for Reducing Convexity or Fullness of Abdominal Subcutaneous Fat Phase 2
Completed NCT04897412 - A Study to Evaluate the Efficacy, Safety, and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 2) Phase 2
Completed NCT03682471 - Long-term 24-month Follow-up Study on Safety and Maintenance of Efficacy of ATX-101 (Sodium Deoxycholate Injection)
Completed NCT05234736 - A Study to Evaluate the Pharmacokinetic Profile of CBL-514 Injection in Healthy Volunteers Phase 2
Completed NCT04575467 - A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 1) Phase 2